COVID-19 Multidisciplinary High Dependency Unit: the Milan Model

Overview

Journal Respir Res

Specialty Pulmonary Medicine

Date 2020 Oct 10

PMID 33036610

Citations 13

Authors

Stefano Aliberti

Francesco Amati

Maria Pappalettera

Marta Di Pasquale

Alice DAdda

Marco Mantero

Andrea Gramegna

Edoardo Simonetta

Anna Maria Oneta

Emilia Privitera

Andrea Gori

Giorgio Bozzi

Flora Peyvandi

Francesca Minoia

Giovanni Filocamo

Chiara Abbruzzese

Marco Vicenzi

Paola Tagliabue

Salvatore Alongi

Francesco Blasi

Affiliations

Soon will be listed here.

Abstract

COVID-19 is a complex and heterogeneous disease. The pathogenesis and the complications of the disease are not fully elucidated, and increasing evidence shows that SARS-CoV-2 causes a systemic inflammatory disease rather than a pulmonary disease. The management of hospitalized patients in COVID-19 dedicated units is advisable for segregation purpose as well as for infection control. In this article we present the standard operating procedures of our COVID-19 high dependency unit of the Policlinico Hospital, in Milan. Our high dependency unit is based on a multidisciplinary approach. We think that the multidisciplinary involvement of several figures can better identify treatable traits of COVID-19 disease, early identify patients who can quickly deteriorate, particularly patients with multiple comorbidities, and better manage complications related to off-label treatments. Although no generalizable to other hospitals and different healthcare settings, we think that our experience and our point of view can be helpful for countries and hospitals that are now starting to face the COVID-19 outbreak.

Citing Articles

Exploring Italian healthcare facilities response to COVID-19 pandemic: Lessons learned from the Italian Response to COVID-19 initiative.

Parotto E, Lamberti-Castronuovo A, Censi V, Valente M, Atzori A, Ragazzoni L Front Public Health. 2023; 10:1016649.

PMID: 36699915 PMC: 9870543. DOI: 10.3389/fpubh.2022.1016649.

Characteristics and Outcomes of Critically Ill Pregnant/Postpartum Women with COVID-19 Pneumonia in Western Balkans, The Republic of Srpska Report.

Kovacevic P, Topolovac S, Dragic S, Jandric M, Momcicevic D, Zlojutro B Medicina (Kaunas). 2022; 58(12).

PMID: 36556932 PMC: 9781202. DOI: 10.3390/medicina58121730.

The COVID-19 pandemic response and its impact on post-corona health emergency and disaster risk management in Italy.

Lamberti-Castronuovo A, Parotto E, Della Corte F, Hubloue I, Ragazzoni L, Valente M Front Public Health. 2022; 10:1034196.

PMID: 36388364 PMC: 9659979. DOI: 10.3389/fpubh.2022.1034196.

The Mortality Risk and Pulmonary Fibrosis Investigated by Time-Resolved Fluorescence Spectroscopy from Plasma in COVID-19 Patients.

Wybranowski T, Pyskir J, Bosek M, Napiorkowska M, Cyrankiewicz M, Ziomkowska B J Clin Med. 2022; 11(17).

PMID: 36079011 PMC: 9457233. DOI: 10.3390/jcm11175081.

Comparison between the first and second COVID-19 waves in Internal Medicine wards in Milan, Italy: a retrospective observational study.

Blanca D, Nicolosi S, Bandera A, Blasi F, Mantero M, Hu C Intern Emerg Med. 2022; 17(8):2219-2228.

PMID: 35970982 PMC: 9377666. DOI: 10.1007/s11739-022-03052-3.

References

Svanstrom H, Pasternak B, Hviid A . Use of azithromycin and death from cardiovascular causes. N Engl J Med. 2013; 368(18):1704-12. DOI: 10.1056/NEJMoa1300799. View

Connors J, Levy J . Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost. 2020; 18(7):1559-1561. PMC: 9770920. DOI: 10.1111/jth.14849. View

McRae S . Pulmonary embolism. Aust Fam Physician. 2010; 39(7):462-6. View

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

Chan J, Yuan S, Kok K, To K, Chu H, Yang J . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-523. PMC: 7159286. DOI: 10.1016/S0140-6736(20)30154-9. View

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D . COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2020; 201(10):1299-1300. PMC: 7233352. DOI: 10.1164/rccm.202003-0817LE. View

Ray W, Murray K, Hall K, Arbogast P, Stein C . Azithromycin and the risk of cardiovascular death. N Engl J Med. 2012; 366(20):1881-90. PMC: 3374857. DOI: 10.1056/NEJMoa1003833. View

Cugno M, Meroni P, Gualtierotti R, Griffini S, Grovetti E, Torri A . Complement activation in patients with COVID-19: A novel therapeutic target. J Allergy Clin Immunol. 2020; 146(1):215-217. PMC: 7224678. DOI: 10.1016/j.jaci.2020.05.006. View

10.

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

11.

Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G . A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020; 382(19):1787-1799. PMC: 7121492. DOI: 10.1056/NEJMoa2001282. View

12.

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View

13.

Halm E, Fine M, Marrie T, Coley C, Kapoor W, Obrosky D . Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA. 1998; 279(18):1452-7. DOI: 10.1001/jama.279.18.1452. View

14.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420-422. PMC: 7164771. DOI: 10.1016/S2213-2600(20)30076-X. View

15.

Alhazzani W, Moller M, Arabi Y, Loeb M, Gong M, Fan E . Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020; 46(5):854-887. PMC: 7101866. DOI: 10.1007/s00134-020-06022-5. View

16.

Matthay M, Aldrich J, Gotts J . Treatment for severe acute respiratory distress syndrome from COVID-19. Lancet Respir Med. 2020; 8(5):433-434. PMC: 7118607. DOI: 10.1016/S2213-2600(20)30127-2. View

17.

Launey Y, Nesseler N, Malledant Y, Seguin P . Clinical review: fever in septic ICU patients--friend or foe?. Crit Care. 2011; 15(3):222. PMC: 3218963. DOI: 10.1186/cc10097. View

18.

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30(3):269-271. PMC: 7054408. DOI: 10.1038/s41422-020-0282-0. View

19.

Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P . In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020; 71(15):732-739. PMC: 7108130. DOI: 10.1093/cid/ciaa237. View

20.

Fisher D, Wilder-Smith A . The global community needs to swiftly ramp up the response to contain COVID-19. Lancet. 2020; 395(10230):1109-1110. PMC: 7138255. DOI: 10.1016/S0140-6736(20)30679-6. View